The global market for Live Attenuated Vaccines for Pets is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Live Attenuated Vaccines for Pets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Live Attenuated Vaccines for Pets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Live Attenuated Vaccines for Pets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Live Attenuated Vaccines for Pets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Live Attenuated Vaccines for Pets players cover Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva and Eli Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Live Attenuated Vaccines for Pets market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Live Attenuated Vaccines for Pets market, with both quantitative and qualitative data, to help readers understand how the Live Attenuated Vaccines for Pets market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Live Attenuated Vaccines for Pets market and forecasts the market size by Type (Virus Attenuated Vaccine and Bacterial Attenuated Vaccine,), by Application (Dog, Cat, Dird and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Virus Attenuated Vaccine
Bacterial Attenuated Vaccine
Segmentation by application
Dog
Cat
Dird
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Chapter Introduction
Chapter 1: Scope of Live Attenuated Vaccines for Pets, Research Methodology, etc.
Chapter 2: Executive Summary, global Live Attenuated Vaccines for Pets market size (sales and revenue) and CAGR, Live Attenuated Vaccines for Pets market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Live Attenuated Vaccines for Pets sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Live Attenuated Vaccines for Pets sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Live Attenuated Vaccines for Pets market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi) and Virbac and etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Live Attenuated Vaccines for Pets Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Live Attenuated Vaccines for Pets by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Live Attenuated Vaccines for Pets by Country/Region, 2017, 2022 & 2028
2.2 Live Attenuated Vaccines for Pets Segment by Type
2.2.1 Virus Attenuated Vaccine
2.2.2 Bacterial Attenuated Vaccine
2.3 Live Attenuated Vaccines for Pets Sales by Type
2.3.1 Global Live Attenuated Vaccines for Pets Sales Market Share by Type (2017-2022)
2.3.2 Global Live Attenuated Vaccines for Pets Revenue and Market Share by Type (2017-2022)
2.3.3 Global Live Attenuated Vaccines for Pets Sale Price by Type (2017-2022)
2.4 Live Attenuated Vaccines for Pets Segment by Application
2.4.1 Dog
2.4.2 Cat
2.4.3 Dird
2.4.4 Others
2.5 Live Attenuated Vaccines for Pets Sales by Application
2.5.1 Global Live Attenuated Vaccines for Pets Sale Market Share by Application (2017-2022)
2.5.2 Global Live Attenuated Vaccines for Pets Revenue and Market Share by Application (2017-2022)
2.5.3 Global Live Attenuated Vaccines for Pets Sale Price by Application (2017-2022)
3 Global Live Attenuated Vaccines for Pets by Company
3.1 Global Live Attenuated Vaccines for Pets Breakdown Data by Company
3.1.1 Global Live Attenuated Vaccines for Pets Annual Sales by Company (2020-2022)
3.1.2 Global Live Attenuated Vaccines for Pets Sales Market Share by Company (2020-2022)
3.2 Global Live Attenuated Vaccines for Pets Annual Revenue by Company (2020-2022)
3.2.1 Global Live Attenuated Vaccines for Pets Revenue by Company (2020-2022)
3.2.2 Global Live Attenuated Vaccines for Pets Revenue Market Share by Company (2020-2022)
3.3 Global Live Attenuated Vaccines for Pets Sale Price by Company
3.4 Key Manufacturers Live Attenuated Vaccines for Pets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Attenuated Vaccines for Pets Product Location Distribution
3.4.2 Players Live Attenuated Vaccines for Pets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Live Attenuated Vaccines for Pets by Geographic Region
4.1 World Historic Live Attenuated Vaccines for Pets Market Size by Geographic Region (2017-2022)
4.1.1 Global Live Attenuated Vaccines for Pets Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Live Attenuated Vaccines for Pets Annual Revenue by Geographic Region
4.2 World Historic Live Attenuated Vaccines for Pets Market Size by Country/Region (2017-2022)
4.2.1 Global Live Attenuated Vaccines for Pets Annual Sales by Country/Region (2017-2022)
4.2.2 Global Live Attenuated Vaccines for Pets Annual Revenue by Country/Region
4.3 Americas Live Attenuated Vaccines for Pets Sales Growth
4.4 APAC Live Attenuated Vaccines for Pets Sales Growth
4.5 Europe Live Attenuated Vaccines for Pets Sales Growth
4.6 Middle East & Africa Live Attenuated Vaccines for Pets Sales Growth
5 Americas
5.1 Americas Live Attenuated Vaccines for Pets Sales by Country
5.1.1 Americas Live Attenuated Vaccines for Pets Sales by Country (2017-2022)
5.1.2 Americas Live Attenuated Vaccines for Pets Revenue by Country (2017-2022)
5.2 Americas Live Attenuated Vaccines for Pets Sales by Type
5.3 Americas Live Attenuated Vaccines for Pets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Attenuated Vaccines for Pets Sales by Region
6.1.1 APAC Live Attenuated Vaccines for Pets Sales by Region (2017-2022)
6.1.2 APAC Live Attenuated Vaccines for Pets Revenue by Region (2017-2022)
6.2 APAC Live Attenuated Vaccines for Pets Sales by Type
6.3 APAC Live Attenuated Vaccines for Pets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Live Attenuated Vaccines for Pets by Country
7.1.1 Europe Live Attenuated Vaccines for Pets Sales by Country (2017-2022)
7.1.2 Europe Live Attenuated Vaccines for Pets Revenue by Country (2017-2022)
7.2 Europe Live Attenuated Vaccines for Pets Sales by Type
7.3 Europe Live Attenuated Vaccines for Pets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Live Attenuated Vaccines for Pets by Country
8.1.1 Middle East & Africa Live Attenuated Vaccines for Pets Sales by Country (2017-2022)
8.1.2 Middle East & Africa Live Attenuated Vaccines for Pets Revenue by Country (2017-2022)
8.2 Middle East & Africa Live Attenuated Vaccines for Pets Sales by Type
8.3 Middle East & Africa Live Attenuated Vaccines for Pets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Attenuated Vaccines for Pets
10.3 Manufacturing Process Analysis of Live Attenuated Vaccines for Pets
10.4 Industry Chain Structure of Live Attenuated Vaccines for Pets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Attenuated Vaccines for Pets Distributors
11.3 Live Attenuated Vaccines for Pets Customer
12 World Forecast Review for Live Attenuated Vaccines for Pets by Geographic Region
12.1 Global Live Attenuated Vaccines for Pets Market Size Forecast by Region
12.1.1 Global Live Attenuated Vaccines for Pets Forecast by Region (2023-2028)
12.1.2 Global Live Attenuated Vaccines for Pets Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Live Attenuated Vaccines for Pets Forecast by Type
12.7 Global Live Attenuated Vaccines for Pets Forecast by Application
13 Key Players Analysis
13.1 Bayer Healthcare
13.1.1 Bayer Healthcare Company Information
13.1.2 Bayer Healthcare Live Attenuated Vaccines for Pets Product Offered
13.1.3 Bayer Healthcare Live Attenuated Vaccines for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Healthcare Main Business Overview
13.1.5 Bayer Healthcare Latest Developments
13.2 Vetoquinol S.A
13.2.1 Vetoquinol S.A Company Information
13.2.2 Vetoquinol S.A Live Attenuated Vaccines for Pets Product Offered
13.2.3 Vetoquinol S.A Live Attenuated Vaccines for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Vetoquinol S.A Main Business Overview
13.2.5 Vetoquinol S.A Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Live Attenuated Vaccines for Pets Product Offered
13.3.3 Boehringer Ingelheim Live Attenuated Vaccines for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Live Attenuated Vaccines for Pets Product Offered
13.4.3 Ceva Live Attenuated Vaccines for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Live Attenuated Vaccines for Pets Product Offered
13.5.3 Eli Lilly Live Attenuated Vaccines for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Heska
13.6.1 Heska Company Information
13.6.2 Heska Live Attenuated Vaccines for Pets Product Offered
13.6.3 Heska Live Attenuated Vaccines for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Heska Main Business Overview
13.6.5 Heska Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Live Attenuated Vaccines for Pets Product Offered
13.7.3 Merck Animal Health Live Attenuated Vaccines for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 Merial (Sanofi)
13.8.1 Merial (Sanofi) Company Information
13.8.2 Merial (Sanofi) Live Attenuated Vaccines for Pets Product Offered
13.8.3 Merial (Sanofi) Live Attenuated Vaccines for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merial (Sanofi) Main Business Overview
13.8.5 Merial (Sanofi) Latest Developments
13.9 Virbac
13.9.1 Virbac Company Information
13.9.2 Virbac Live Attenuated Vaccines for Pets Product Offered
13.9.3 Virbac Live Attenuated Vaccines for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Virbac Main Business Overview
13.9.5 Virbac Latest Developments
13.10 Zoetis (Pfizer)
13.10.1 Zoetis (Pfizer) Company Information
13.10.2 Zoetis (Pfizer) Live Attenuated Vaccines for Pets Product Offered
13.10.3 Zoetis (Pfizer) Live Attenuated Vaccines for Pets Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Zoetis (Pfizer) Main Business Overview
13.10.5 Zoetis (Pfizer) Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Live Attenuated Vaccines for Pets Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Live Attenuated Vaccines for Pets Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Virus Attenuated Vaccine
Table 4. Major Players of Bacterial Attenuated Vaccine
Table 5. Global Live Attenuated Vaccines for Pets Sales by Type (2017-2022) & (K Units)
Table 6. Global Live Attenuated Vaccines for Pets Sales Market Share by Type (2017-2022)
Table 7. Global Live Attenuated Vaccines for Pets Revenue by Type (2017-2022) & ($ million)
Table 8. Global Live Attenuated Vaccines for Pets Revenue Market Share by Type (2017-2022)
Table 9. Global Live Attenuated Vaccines for Pets Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Live Attenuated Vaccines for Pets Sales by Application (2017-2022) & (K Units)
Table 11. Global Live Attenuated Vaccines for Pets Sales Market Share by Application (2017-2022)
Table 12. Global Live Attenuated Vaccines for Pets Revenue by Application (2017-2022)
Table 13. Global Live Attenuated Vaccines for Pets Revenue Market Share by Application (2017-2022)
Table 14. Global Live Attenuated Vaccines for Pets Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Live Attenuated Vaccines for Pets Sales by Company (2020-2022) & (K Units)
Table 16. Global Live Attenuated Vaccines for Pets Sales Market Share by Company (2020-2022)
Table 17. Global Live Attenuated Vaccines for Pets Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Live Attenuated Vaccines for Pets Revenue Market Share by Company (2020-2022)
Table 19. Global Live Attenuated Vaccines for Pets Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Live Attenuated Vaccines for Pets Producing Area Distribution and Sales Area
Table 21. Players Live Attenuated Vaccines for Pets Products Offered
Table 22. Live Attenuated Vaccines for Pets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Live Attenuated Vaccines for Pets Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Live Attenuated Vaccines for Pets Sales Market Share Geographic Region (2017-2022)
Table 27. Global Live Attenuated Vaccines for Pets Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Live Attenuated Vaccines for Pets Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Live Attenuated Vaccines for Pets Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Live Attenuated Vaccines for Pets Sales Market Share by Country/Region (2017-2022)
Table 31. Global Live Attenuated Vaccines for Pets Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Live Attenuated Vaccines for Pets Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Live Attenuated Vaccines for Pets Sales by Country (2017-2022) & (K Units)
Table 34. Americas Live Attenuated Vaccines for Pets Sales Market Share by Country (2017-2022)
Table 35. Americas Live Attenuated Vaccines for Pets Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Live Attenuated Vaccines for Pets Revenue Market Share by Country (2017-2022)
Table 37. Americas Live Attenuated Vaccines for Pets Sales by Type (2017-2022) & (K Units)
Table 38. Americas Live Attenuated Vaccines for Pets Sales Market Share by Type (2017-2022)
Table 39. Americas Live Attenuated Vaccines for Pets Sales by Application (2017-2022) & (K Units)
Table 40. Americas Live Attenuated Vaccines for Pets Sales Market Share by Application (2017-2022)
Table 41. APAC Live Attenuated Vaccines for Pets Sales by Region (2017-2022) & (K Units)
Table 42. APAC Live Attenuated Vaccines for Pets Sales Market Share by Region (2017-2022)
Table 43. APAC Live Attenuated Vaccines for Pets Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Live Attenuated Vaccines for Pets Revenue Market Share by Region (2017-2022)
Table 45. APAC Live Attenuated Vaccines for Pets Sales by Type (2017-2022) & (K Units)
Table 46. APAC Live Attenuated Vaccines for Pets Sales Market Share by Type (2017-2022)
Table 47. APAC Live Attenuated Vaccines for Pets Sales by Application (2017-2022) & (K Units)
Table 48. APAC Live Attenuated Vaccines for Pets Sales Market Share by Application (2017-2022)
Table 49. Europe Live Attenuated Vaccines for Pets Sales by Country (2017-2022) & (K Units)
Table 50. Europe Live Attenuated Vaccines for Pets Sales Market Share by Country (2017-2022)
Table 51. Europe Live Attenuated Vaccines for Pets Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Live Attenuated Vaccines for Pets Revenue Market Share by Country (2017-2022)
Table 53. Europe Live Attenuated Vaccines for Pets Sales by Type (2017-2022) & (K Units)
Table 54. Europe Live Attenuated Vaccines for Pets Sales Market Share by Type (2017-2022)
Table 55. Europe Live Attenuated Vaccines for Pets Sales by Application (2017-2022) & (K Units)
Table 56. Europe Live Attenuated Vaccines for Pets Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Live Attenuated Vaccines for Pets Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Live Attenuated Vaccines for Pets Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Live Attenuated Vaccines for Pets Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Live Attenuated Vaccines for Pets Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Live Attenuated Vaccines for Pets Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Live Attenuated Vaccines for Pets Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Live Attenuated Vaccines for Pets Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Live Attenuated Vaccines for Pets Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Live Attenuated Vaccines for Pets
Table 66. Key Market Challenges & Risks of Live Attenuated Vaccines for Pets
Table 67. Key Industry Trends of Live Attenuated Vaccines for Pets
Table 68. Live Attenuated Vaccines for Pets Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Live Attenuated Vaccines for Pets Distributors List
Table 71. Live Attenuated Vaccines for Pets Customer List
Table 72. Global Live Attenuated Vaccines for Pets Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Live Attenuated Vaccines for Pets Sales Market Forecast by Region
Table 74. Global Live Attenuated Vaccines for Pets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Live Attenuated Vaccines for Pets Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Live Attenuated Vaccines for Pets Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Live Attenuated Vaccines for Pets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Live Attenuated Vaccines for Pets Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Live Attenuated Vaccines for Pets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Live Attenuated Vaccines for Pets Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Live Attenuated Vaccines for Pets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Live Attenuated Vaccines for Pets Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Live Attenuated Vaccines for Pets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Live Attenuated Vaccines for Pets Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Live Attenuated Vaccines for Pets Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Live Attenuated Vaccines for Pets Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Live Attenuated Vaccines for Pets Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Live Attenuated Vaccines for Pets Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Live Attenuated Vaccines for Pets Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Live Attenuated Vaccines for Pets Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Live Attenuated Vaccines for Pets Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bayer Healthcare Basic Information, Live Attenuated Vaccines for Pets Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer Healthcare Live Attenuated Vaccines for Pets Product Offered
Table 94. Bayer Healthcare Live Attenuated Vaccines for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Bayer Healthcare Main Business
Table 96. Bayer Healthcare Latest Developments
Table 97. Vetoquinol S.A Basic Information, Live Attenuated Vaccines for Pets Manufacturing Base, Sales Area and Its Competitors
Table 98. Vetoquinol S.A Live Attenuated Vaccines for Pets Product Offered
Table 99. Vetoquinol S.A Live Attenuated Vaccines for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Vetoquinol S.A Main Business
Table 101. Vetoquinol S.A Latest Developments
Table 102. Boehringer Ingelheim Basic Information, Live Attenuated Vaccines for Pets Manufacturing Base, Sales Area and Its Competitors
Table 103. Boehringer Ingelheim Live Attenuated Vaccines for Pets Product Offered
Table 104. Boehringer Ingelheim Live Attenuated Vaccines for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Boehringer Ingelheim Main Business
Table 106. Boehringer Ingelheim Latest Developments
Table 107. Ceva Basic Information, Live Attenuated Vaccines for Pets Manufacturing Base, Sales Area and Its Competitors
Table 108. Ceva Live Attenuated Vaccines for Pets Product Offered
Table 109. Ceva Live Attenuated Vaccines for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Ceva Main Business
Table 111. Ceva Latest Developments
Table 112. Eli Lilly Basic Information, Live Attenuated Vaccines for Pets Manufacturing Base, Sales Area and Its Competitors
Table 113. Eli Lilly Live Attenuated Vaccines for Pets Product Offered
Table 114. Eli Lilly Live Attenuated Vaccines for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Eli Lilly Main Business
Table 116. Eli Lilly Latest Developments
Table 117. Heska Basic Information, Live Attenuated Vaccines for Pets Manufacturing Base, Sales Area and Its Competitors
Table 118. Heska Live Attenuated Vaccines for Pets Product Offered
Table 119. Heska Live Attenuated Vaccines for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Heska Main Business
Table 121. Heska Latest Developments
Table 122. Merck Animal Health Basic Information, Live Attenuated Vaccines for Pets Manufacturing Base, Sales Area and Its Competitors
Table 123. Merck Animal Health Live Attenuated Vaccines for Pets Product Offered
Table 124. Merck Animal Health Live Attenuated Vaccines for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Merck Animal Health Main Business
Table 126. Merck Animal Health Latest Developments
Table 127. Merial (Sanofi) Basic Information, Live Attenuated Vaccines for Pets Manufacturing Base, Sales Area and Its Competitors
Table 128. Merial (Sanofi) Live Attenuated Vaccines for Pets Product Offered
Table 129. Merial (Sanofi) Live Attenuated Vaccines for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Merial (Sanofi) Main Business
Table 131. Merial (Sanofi) Latest Developments
Table 132. Virbac Basic Information, Live Attenuated Vaccines for Pets Manufacturing Base, Sales Area and Its Competitors
Table 133. Virbac Live Attenuated Vaccines for Pets Product Offered
Table 134. Virbac Live Attenuated Vaccines for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Virbac Main Business
Table 136. Virbac Latest Developments
Table 137. Zoetis (Pfizer) Basic Information, Live Attenuated Vaccines for Pets Manufacturing Base, Sales Area and Its Competitors
Table 138. Zoetis (Pfizer) Live Attenuated Vaccines for Pets Product Offered
Table 139. Zoetis (Pfizer) Live Attenuated Vaccines for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Zoetis (Pfizer) Main Business
Table 141. Zoetis (Pfizer) Latest Developments
List of Figures
Figure 1. Picture of Live Attenuated Vaccines for Pets
Figure 2. Live Attenuated Vaccines for Pets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Attenuated Vaccines for Pets Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Live Attenuated Vaccines for Pets Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Live Attenuated Vaccines for Pets Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Virus Attenuated Vaccine
Figure 10. Product Picture of Bacterial Attenuated Vaccine
Figure 11. Global Live Attenuated Vaccines for Pets Sales Market Share by Type in 2021
Figure 12. Global Live Attenuated Vaccines for Pets Revenue Market Share by Type (2017-2022)
Figure 13. Live Attenuated Vaccines for Pets Consumed in Dog
Figure 14. Global Live Attenuated Vaccines for Pets Market: Dog (2017-2022) & (K Units)
Figure 15. Live Attenuated Vaccines for Pets Consumed in Cat
Figure 16. Global Live Attenuated Vaccines for Pets Market: Cat (2017-2022) & (K Units)
Figure 17. Live Attenuated Vaccines for Pets Consumed in Dird
Figure 18. Global Live Attenuated Vaccines for Pets Market: Dird (2017-2022) & (K Units)
Figure 19. Live Attenuated Vaccines for Pets Consumed in Others
Figure 20. Global Live Attenuated Vaccines for Pets Market: Others (2017-2022) & (K Units)
Figure 21. Global Live Attenuated Vaccines for Pets Sales Market Share by Application (2017-2022)
Figure 22. Global Live Attenuated Vaccines for Pets Revenue Market Share by Application in 2021
Figure 23. Live Attenuated Vaccines for Pets Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Live Attenuated Vaccines for Pets Revenue Market Share by Company in 2021
Figure 25. Global Live Attenuated Vaccines for Pets Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Live Attenuated Vaccines for Pets Revenue Market Share by Geographic Region in 2021
Figure 27. Global Live Attenuated Vaccines for Pets Sales Market Share by Region (2017-2022)
Figure 28. Global Live Attenuated Vaccines for Pets Revenue Market Share by Country/Region in 2021
Figure 29. Americas Live Attenuated Vaccines for Pets Sales 2017-2022 (K Units)
Figure 30. Americas Live Attenuated Vaccines for Pets Revenue 2017-2022 ($ Millions)
Figure 31. APAC Live Attenuated Vaccines for Pets Sales 2017-2022 (K Units)
Figure 32. APAC Live Attenuated Vaccines for Pets Revenue 2017-2022 ($ Millions)
Figure 33. Europe Live Attenuated Vaccines for Pets Sales 2017-2022 (K Units)
Figure 34. Europe Live Attenuated Vaccines for Pets Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Live Attenuated Vaccines for Pets Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Live Attenuated Vaccines for Pets Revenue 2017-2022 ($ Millions)
Figure 37. Americas Live Attenuated Vaccines for Pets Sales Market Share by Country in 2021
Figure 38. Americas Live Attenuated Vaccines for Pets Revenue Market Share by Country in 2021
Figure 39. United States Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Live Attenuated Vaccines for Pets Sales Market Share by Region in 2021
Figure 44. APAC Live Attenuated Vaccines for Pets Revenue Market Share by Regions in 2021
Figure 45. China Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Live Attenuated Vaccines for Pets Sales Market Share by Country in 2021
Figure 52. Europe Live Attenuated Vaccines for Pets Revenue Market Share by Country in 2021
Figure 53. Germany Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Live Attenuated Vaccines for Pets Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Live Attenuated Vaccines for Pets Revenue Market Share by Country in 2021
Figure 60. Egypt Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Live Attenuated Vaccines for Pets Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Live Attenuated Vaccines for Pets in 2021
Figure 66. Manufacturing Process Analysis of Live Attenuated Vaccines for Pets
Figure 67. Industry Chain Structure of Live Attenuated Vaccines for Pets
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)